📈 Jumpstart Signal Watchlist — September 29, 2026

🏢 What they do: Grindr Inc. operates a location-based social networking and dating platform primarily serving gay, bisexual, transgender, queer, and other LGBTQ+ adults. Its mobile app enables users to discover, connect, chat, and share content with nearby or global users, with features offered through free and subscription tiers.
- 🎯 Current $16.12 is 35% below 3yr high $24.73 · ⏳ SMA200 $13.60 (current price $16.12 is above) · 💰 Market Cap $2.8B
- GRND shows decent technicals supported by positive sentiment.

💎 Quality (Q): 39/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 25% (>20%); Revenue growth 33% (>15%); PEG ratio 1.29 (<1.5).
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×3 ❌×1 ⚪️×1; showing 4 of 5).
✅ Grindr at Goldman Sachs Communacopia + Technology Conference 2026: AI Drives Growth — Investing.com.
🤖 At the September 10 conference, management described growth in users and revenue and a stronger focus on AI. The reported increase in paying users and monetization supports a positive outlook, though execution remains important.
✅ Morgan Stanley reiterates Grindr stock rating on monetization potential — Investing.com.
🤖 Morgan Stanley reiterated its Overweight rating and $20 price target, citing monetization potential, an underappreciated competitive moat, and product-led catalysts. The analyst’s favorable view is a positive signal for the stock.
❌ Is Grindr (GRND) Priced For Too Much Earnings Optimism? — Yahoo Finance.
🤖 The article questions whether the stock’s valuation reflects excessive earnings optimism, noting it trades at about 32.2 times earnings. That valuation concern could weigh on shares if growth does not meet expectations.
⚪️ Grindr’s Award-Winning Podcast, Who’s the Ahole? Is Back for a Fifth Round — Business Wire.
🤖 The article announces another season of Grindr’s podcast, a brand and content initiative. It does not report a material financial result or change in guidance.
🍭 Bonus (B): 10/10** — Computer Programming & Data Processing (Technology sector)

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $25.67 is 3% below 3yr high $26.52 · ⏳ SMA200 $16.76 (current price $25.67 is above) · 💰 Market Cap $3.7B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 3/20
- 🔔 Strong above EMA21 (6.3%)
- 🔔 Strong above EMA50 (12.4%)
- 📈 RSI at 62 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ Magnite could be a big winner as DOJ takes aim at Google's ad dominance -- BofA (MGNI:NASDAQ) — Seeking Alpha.
🤖 BofA Securities raised its price target on Magnite to $38, citing potential benefits from the DOJ’s proposed remedies in its ad-tech case against Google. The analyst sees the remedies as a meaningful opportunity for Magnite’s growth.
✅ Magnite Named Primary Video Ad Server and a Programmatic Technology Provider for HP TV+ — GlobeNewswire.
🤖 HP TV+ selected Magnite as its primary video ad server and programmatic technology provider, including for banner and video inventory. The partnership expands Magnite’s distribution and potential advertising demand.
⚪️ Magnite Chairman Sells 7,500 Shares Near the Stock's 52-Week High — Yahoo Finance.
🤖 Magnite’s chairman disclosed a sale of 7,500 shares. The article also notes strong second-quarter revenue and net income growth, but the reported insider sale itself is not a clear directional catalyst.
⚪️ Magnite Promotes Brian Gephart to Chief Financial Officer — GlobeNewswire.
🤖 Magnite announced Brian Gephart’s promotion to CFO, effective October 1. The article reports a leadership transition but does not describe a financial outlook change or other clear stock catalyst.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 Current $58.65 is 1% below 3yr high $59.13 · ⏳ SMA200 $48.65 (current price $58.65 is above) · 💰 Market Cap $14.6B
- EXEL shows favorable technicals but negative sentiment warrants caution.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (11.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 26% (>20%); ROE 47% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 1/10
- 🗞️ News sentiment is negative (❌×4 ⚪️×1; showing 3 of 5).
❌ Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans? — Zacks.
🤖 The FDA extended its review of zanzalintinib for metastatic colorectal cancer by three months, moving the target decision date to March 3, 2027. The delay postpones a potential approval and related revenue opportunity.
❌ Exelixis Shares Fall 3.5% as FDA Extends Zanzalintinib Review by Three Months — Yahoo Finance.
🤖 The FDA's three-month review extension for zanzalintinib plus atezolizumab pushed the decision date to March 3, 2027. The report noted EXEL shares fell 3.5% in premarket trading after the news.
⚪️ Exelixis at Citigroup summit: building a second growth engine — Investing.com.
🤖 Management described CABOMETYX's commercial position and zanzalintinib's potential as a second growth franchise, while also acknowledging development risk from a setback in frontline kidney cancer. The growth opportunities and risks make the report mixed.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Worthington Enterprises designs and manufactures building and consumer products, including HVAC and water systems, metal roofing and ceiling components, tools, portable propane and helium cylinders, outdoor-living products, and celebration supplies. Its brands include Bernzomatic, Balloon Time, Coleman propane cylinders, Garden Weasel, and LEVEL5 Tools.
- 🎯 Current $59.94 is 11% below 3yr high $67.39 · ⏳ SMA200 $55.35 (current price $59.94 is above) · 💰 Market Cap $2.9B
- WOR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 978% (>20%); ROE 15% (>15%); Low LT D/E 0.30 (<1.0).
⏰ Entry (E): 2/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Worthington Enterprises Reports First Quarter Fiscal 2027 — GlobeNewswire.
🤖 Fiscal first-quarter sales rose 13% to $343.9 million and adjusted EPS increased to $0.82 from $0.78 a year earlier. Adjusted EBITDA and free cash flow also grew, indicating stronger operating performance.
✅ Worthington Enterprises Q1 Earnings Call Highlights — Yahoo Finance.
🤖 The earnings-call coverage highlights 13% sales growth, higher adjusted EPS and EBITDA, and $13 million in quarterly revenue from engineered tanks for data centers. It also notes housing and other operating headwinds, but the reported growth and emerging data-center demand are favorable.
⚪️ Worthington Enterprises Announces Investor Day; Renames Business Segments — Yahoo Finance.
🤖 Worthington announced an upcoming investor and analyst day and renamed its two business segments to better reflect their markets. The company said the changes are names only and do not affect segment composition or historical financial results.
🍭 Bonus (B): 0/10 — Steel Works & Blast Furnaces

🏢 What they do: Hewlett Packard Enterprise (HPE) is an enterprise technology company that provides compute, storage, networking, and software solutions designed for hybrid IT environments and AI infrastructure.
- 🎯 Current $61.49 is 3% below 3yr high $63.52 · ⏳ SMA200 $36.06 (current price $61.49 is above) · 💰 Market Cap $81.7B
- HPE shows decent technicals supported by positive sentiment.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 405% (>20%); Revenue growth 34% (>15%); Low LT D/E 0.82 (<1.0); PEG ratio 0.08 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (12.0%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ HPE's Networking Orders Signal Continued Growth — Zacks.
🤖 HPE’s networking orders and AI infrastructure demand point to continued growth, with the article also noting a gigawatt-scale Oracle deal for routers and switches. The expanded Juniper portfolio broadens HPE’s reach across networking markets.
✅ Bull of the Day: Hewlett Packard Enterprise (HPE) — Zacks.
🤖 The article highlights HPE’s strong third-quarter results, raised outlook, record orders and backlog, and new AI-related business. It also cites the Juniper integration and analyst estimate increases as supportive factors.
⚪️ Hewlett Packard Enterprise Company (NYSE:HPE) Shares Climb 1.9% - Here's Why — MarketBeat.
🤖 The article reports a generally positive analyst consensus and several price-target increases, but also notes an Evercore downgrade and competitive risks. The mixed analyst details do not point clearly in one direction overall.
⚪️ Hewlett Packard Enterprise at Citi's 2026 Global TMT Conference: Demand Surges — Investing.com.
🤖 HPE described strong demand across networking, cloud and AI, but cautioned that margins could ease from a record level in the current quarter. The growth outlook is encouraging, while the margin warning offsets some of that positive signal.
🍭 Bonus (B): 10/10 — Computer & Office Equipment (Technology sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $35.34 is 3% below 3yr high $36.37 · ⏳ SMA200 $26.33 (current price $35.34 is above) · 💰 Market Cap $4.5B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (6.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 46% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Concentra Group Holdings Parent (CON) Beats Again And Expands In Florida, Is The Stock Still Undervalued? — Yahoo Finance.
🤖 The article notes an August earnings beat and the opening of a new occupational health center in Daytona Beach, expanding Concentra’s footprint. It also says the shares were below a cited fair-value estimate, though trading at a somewhat higher P/E than peers.
✅ Consensus Concentra Group Holdings Parent, Inc. (NYSE:CON) Receives Consensus Rating of Buy from Brokerages — MarketBeat.
🤖 The article reports a consensus Buy rating from eight analysts and an average 12-month price target of $39.40. It also notes JPMorgan raised its target to $43 and maintained an Overweight rating.
⚪️ Concentra appoints Tanner Newton as CFO (CON:NYSE) — Seeking Alpha.
🤖 Concentra appointed strategy and finance executive Tanner Newton as CFO, effective November 1, 2026, as Matt DiCanio is set to become CEO. The leadership transition is company-specific but the article provides no clear financial impact.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities